TY - JOUR
T1 - Pulmonary Infiltrates and Eosinophilia Associated With Sulfasalazine
AU - WANG, KENNETH K.
AU - BOWYER, BRAD A.
AU - FLEMING, C. RICHARD
AU - SCHROEDER, KENNETH W.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1984
Y1 - 1984
N2 - Asymptomatic pulmonary infiltrates and eosinophilia developed in a patient with chronic ulcerative colitis 1 month after therapy with sulfasalazine had been instituted. The abnormalities resolved completely after use of the drug was discontinued. The sulfapyridine component of the sulfasalazine was the likely causative agent because 41 years earlier, the patient had experienced fever, myalgias, and eosinophilia after taking a sulfonamide. Ten previous cases of sulfasalazine pulmonary toxicity, including one fatality, have been reported.
AB - Asymptomatic pulmonary infiltrates and eosinophilia developed in a patient with chronic ulcerative colitis 1 month after therapy with sulfasalazine had been instituted. The abnormalities resolved completely after use of the drug was discontinued. The sulfapyridine component of the sulfasalazine was the likely causative agent because 41 years earlier, the patient had experienced fever, myalgias, and eosinophilia after taking a sulfonamide. Ten previous cases of sulfasalazine pulmonary toxicity, including one fatality, have been reported.
UR - http://www.scopus.com/inward/record.url?scp=0021195741&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021195741&partnerID=8YFLogxK
U2 - 10.1016/S0025-6196(12)61431-1
DO - 10.1016/S0025-6196(12)61431-1
M3 - Article
C2 - 6144819
AN - SCOPUS:0021195741
SN - 0025-6196
VL - 59
SP - 343
EP - 346
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 5
ER -